| COUNTRY | Nº APPLICATION, PUBLICATION AND/OR GRANT | STATUS | TITLE | INVENTORS |
|---|---|---|---|---|
| USA | US 13/119,162 US 8,815,885 | Issued | Methods & Compositions for Modulating lre 1, Src, and Abl Activity. | P. Walter, K. Shokat, A. Korennykh, C. Zhang, J. Finer-Moore, R. Stroud, P. Egea, A. Dar, A. Korostelev, S. Bernales |
| USA | US 14/322,765 US 9382230 | Issued | Methods & Compositions for Modulating lre 1, Src, and Abl Activity. | P. Walter, K. Shokat, A. Korennykh, C. Zhang, J. Finer-Moore, R. Stroud, P. Egea, A. Dar, A. Korostelev, S. Bernales |
| AUSTRALIA | AU 2009290617 B2 | Issued | Methods & Compositions for Modulating lre 1, Src, and Abl Activity. | P. Walter, K. Shokat, A. Korennykh, C. Zhang, J. Finer-Moore, R. Stroud, P. Egea, A. Dar, A. Korostelev, S. Bernales |
| CANADA | CA 2737388 | Issued | Methods & Compositions for Modulating lre 1, Src, and Abl Activity. | P. Walter, K. Shokat, A. Korennykh, C. Zhang, J. Finer-Moore, R. Stroud, P. Egea, A. Dar, A. Korostelev, S. Bernales |
| CHINA | CN 200980145225 CN 102264728 B | Issued | Methods & Compositions for Modulating lre 1, Src, and Abl Activity. | P. Walter, K. Shokat, A. Korennykh, C. Zhang, J. Finer-Moore, R. Stroud, P. Egea, A. Dar, A. Korostelev, S. Bernales |
| HONG KONG | HK 20120104444 HK 1163689 | Issued | Methods & Compositions for Modulating lre 1, Src, and Abl Activity. | P. Walter, K. Shokat, A. Korennykh, C. Zhang, J. Finer-Moore, R. Stroud, P. Egea, A. Dar, A. Korostelev, S. Bernales |
| JAPON | JP 20110527045 JP 6144873 | Issued | Methods & Compositions for Modulating lre 1, Src, and Abl Activity. | P. Walter, K. Shokat, A. Korennykh, C. Zhang, J. Finer-Moore, R. Stroud, P. Egea, A. Dar, A. Korostelev, S. Bernales |
| EUROPE Validated in: France, Germany, UK, Switzerland. | EP 09813799.5 EP 2340248 B1 | Issued | Methods & Compositions for Modulating lre 1, Src, and Abl Activity. | P. Walter, K. Shokat, A. Korennykh, C. Zhang, J. Finer-Moore, R. Stroud, P. Egea, A. Dar, A. Korostelev, S. Bernales |
| USA | US 10/557,458 US 8,318,686 | Issued | Markers for Pre-cancer and Cancer Cells and Method to Interfere with Cell Proliferation Therein. | L. Burzio, J. Villegas, V. Burzio |
| USA | US 13/627,965 US 8,895,719 | Issued | Markers for Pre-cancer and Cancer Cells and Method to Interfere with Cell Proliferation Therein. | L. Burzio, J. Villegas, V. Burzio |
| USA | US 14/479,143 US 9,359,648 | Issued | Markers for Pre-cancer and Cancer Cells and Method to Interfere with Cell Proliferation Therein. | L. Burzio, J. Villegas, V. Burzio |
| USA | US 15/139,255 US 9,903,000 | Issued | Markers for Pre-cancer and Cancer Cells and Method to Interfere with Cell Proliferation Therein. | L. Burzio, J. Villegas, V. Burzio |
| USA | US 15/867,627 2018-0340332 | Pending | Markers for Pre-cancer and Cancer Cells and Method to Interfere with Cell Proliferation Therein. | L. Burzio, J. Villegas, V. Burzio |
| BRAZIL | PI 0410789-6 A | Pending | Markers for Pre-cancer and Cancer Cells and Method to Interfere with Cell Proliferation Therein. | L. Burzio, J. Villegas, V. Burzio |
| CANADA | CA 2526639 | Issued | Markers for Pre-cancer and Cancer Cells and Method to Interfere with Cell Proliferation Therein. | L. Burzio, J. Villegas, V. Burzio |
| JAPAN | JP 20060533267 JP 5201834 | Issued | Markers for Pre-cancer and Cancer Cells and Method to Interfere with Cell Proliferation Therein. | L. Burzio, J. Villegas, V. Burzio |
| JAPAN | JP 20120269587 JP 5775057 | Issued | Markers for Pre-cancer and Cancer Cells and Method to Interfere with Cell Proliferation Therein. | L. Burzio, J. Villegas, V. Burzio |
| MEXICO | PA/A/2005/012620 285484 | Issued | Markers for Pre-cancer and Cancer Cells and Method to Interfere with Cell Proliferation Therein. | L. Burzio, J. Villegas, V. Burzio |
| MEXICO | MX/A/2010/013431 294004 | Issued | Markers for Pre-cancer and Cancer Cells and Method to Interfere with Cell Proliferation Therein. | L. Burzio, J. Villegas, V. Burzio |
| MEXICO | MX/A/2010/013430 304828 | Issued | Markers for Pre-cancer and Cancer Cells and Method to Interfere with Cell Proliferation Therein. | L. Burzio, J. Villegas, V. Burzio |
| MEXICO | MX/A/2012/012747 309892 | Issued | Markers for Pre-cancer and Cancer Cells and Method to Interfere with Cell Proliferation Therein. | L. Burzio, J. Villegas, V. Burzio |
| EUROPE Validated in: Belgium, France, Germany, Italy, Poland, Spain, Turkey, UK. | EP 20040752867 EP 1625142 B1 | Issued | Markers for Pre-cancer and Cancer Cells and Method to Interfere with Cell Proliferation Therein. | L. Burzio, J. Villegas, V. Burzio |
| EUROPE Validated in: Belgium, France, Germany, Italy, Poland, Spain, Turkey, UK. | EP 20100171933 EP 2264170 B1 | Issued | Markers for Pre-cancer and Cancer Cells and Method to Interfere with Cell Proliferation Therein. | L. Burzio, J. Villegas, V. Burzio |
| EUROPE Validated in: Belgium, France, Germany, Italy, Poland, Spain, Turkey, UK. | EP 20100171926 EP 2270159 B1 | Issued | Markers for Pre-cancer and Cancer Cells and Method to Interfere with Cell Proliferation Therein. | L. Burzio, J. Villegas, V. Burzio |
| USA | US 14/776,260 US 10,066,269 | Issued | Methods for Detecting and Treating Multiple Myeloma. | L. Burzio, J. Villegas, V. Burzio, C. Villota |
| EUROPE Validated in: France, UK, Germany. | EP 14771119.6 EP 2970364 A2 | Issued | Methods for Detecting and Treating Multiple Myeloma. | L. Burzio, J. Villegas, V. Burzio, C. Villota |
| USA | US 14/775,654 US 9,862,944 | Issued | Antisense Oligonucleotides for Treatment of Cancer Stem Cells. | L. Burzio, J. Villegas, V. Burzio, C. Villota |
| USA | US 15/826,535 US 10,457,943 | Issued | Antisense Oligonucleotides for Treatment of Cancer Stem Cells. | L. Burzio, J. Villegas, V. Burzio, C. Villota |
| USA | US 16/573,983 US 2020-0239885 | Pending | Antisense Oligonucleotides for Treatment of Cancer Stem Cells. | L. Burzio, J. Villegas, V. Burzio, C. Villota |
| BRAZIL | BR 112015022308-7 | Pending | Antisense Oligonucleotides for Treatment of Cancer Stem Cells. | L. Burzio, J. Villegas, V. Burzio, C. Villota |
| CANADA | CA 2906198 | Pending | Antisense Oligonucleotides for Treatment of Cancer Stem Cells. | L. Burzio, J. Villegas, V. Burzio, C. Villota |
| CHINA | CN 201480026262.3 CN 105229150 | Pending | Antisense Oligonucleotides for Treatment of Cancer Stem Cells. | L. Burzio, J. Villegas, V. Burzio, C. Villota |
| HONG KONG | HK 16108389.4 HK 1220482 | Issued | Antisense Oligonucleotides for Treatment of Cancer Stem Cells. | L. Burzio, J. Villegas, V. Burzio, C. Villota |
| JAPON | JP 2016-503160 JP 6313419 | Issued | Antisense Oligonucleotides for Treatment of Cancer Stem Cells. | L. Burzio, J. Villegas, V. Burzio, C. Villota |
| MEXICO | MX/A/15/012063 MX 359337 | Issued | Antisense Oligonucleotides for Treatment of Cancer Stem Cells. | L. Burzio, J. Villegas, V. Burzio, C. Villota |
| EUROPE Validated in: France, UK, Germany, Belgium, Italy, Spain, Switzerland, Turkey, Netherlands, Poland, Sweden, Greece, Hungary, Austria, Czech Republic, Ireland, Denmark. | EP 14770117.7 EP 2970970 | Issued | Antisense Oligonucleotides for Treatment of Cancer Stem Cells. | L. Burzio, J. Villegas, V. Burzio, C. Villota |
| EUROPE | EP 15772736.3 EP 3116513 A2 | Pending | Pharmaceutical Compositions Comprising RNA and Use for Treating Cancer | L. Burzio, V. Burzio |
| PCT | PCT/US2009/056993 WO/2010/031056 | National Phase | Methods & Compositions for Modulating lve 1, Src, and Ab1 Activity. | P. Walter, K. Shokat, A. Korennykh, C. Zhang, J. Finer-Moore, R. Stroud, P. Egea, A. Dar, A. Korostelev, S. Bernales |
| PCT | PCT/US04/015929 WO/2005/001030 | National Phase | Markers for Pre-cancer and Cancer Cells and Method to Interfere with Cell Proliferation Therein. | L. Burzio, J. Villegas, V. Burzio |
| PCT | PCT/US2014/029602 WO/2014/153206 | National Phase | Methods for Detecting and Treating Multiple Myeloma. | L. Burzio, J. Villegas, V. Burzio, C. Villota |
| PCT | PCT/US2014/029606 WO/2014/153209 | National Phase | Antisense Oligonucleotides for Treatment of Cancer Stem Cells. | L. Burzio, J. Villegas, V. Burzio, C. Villota |
| PCT | PCT/IB2015/001233 WO/2015/150924 | National Phase | Pharmaceutical Compositions Comprising RNA and Use for Treating Cancer | L. Burzio, V. Burzio |
| PCT | PCT/US2019/022134 WO/2019/178286 | National Phase | Engineered spike proteins of hantaviruses and uses thereof | N. Tischler, E. Bignon, F. Rey, P. Guardado. |
| PCT | PCT/IB2017/051868 WO2017168390 A2 | Expired | Attenuation of neurodegeneration associated with Parkinson's disease by inhibition of the dopamine D3 receptor in CD4+ T cells | R. Pacheco, H. González, D. Elgueta, F. Contreras, V. Ugalde. |
| PCT | PCT/IB2017/053045 WO2017203436 A2 | Expired | Hanta virus Gc fragments inhibiting the fusion of the virus with a cell | N. Tischler, G. Barriga. |
| PCT | PCT/CL2015/050033 WO2016023137 | Expired | Ultra-thin and self-hydrating interface comprising a biopolymer. | T. Pérez-Acle, U. Volkmann, S. Gutiérrez, M. J. Retamal, M. Cisternas |